|
很少发帖,但这个股后劲微小,我下昼反映过去去买26c都没比及。这个次要做心梗的预警零碎。是第一款这种产品FDA批准,当初澳洲和新加坡。他们失掉亚洲的八个国度繁多供给合同,觉得股价还会向上,有兴致能够关注下
“The successful implants follow Hydrix’s announcement on 13 March 2020 that it had acquired an exclusive seven-year distribution agreement for eight Asia Pacific countries to distribute the AngelMed Guardian device, the world’s first FDA approved implantable heart attack warning system.“ |
|